TAK1 Regulates the Nrf2 Antioxidant System Through Modulating p62/SQSTM1

Antioxidants and Redox Signaling

Volumn 25, Issue 17, 2016, Pages 953-964

  Hashimoto, Kazunori ^a   Simmons, Alicia N ^a   Kajino Sakamoto, Rie ^a   Tsuji, Yoshiaki ^a   Ninomiya Tsuji, Jun ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

intestine; Keap1; Nrf2; p62 SQSTM; TAK1

Indexed keywords

ADAPTOR PROTEIN; INTERLEUKIN 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; SEQUESTOSOME 1; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; ANTIOXIDANT; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN BINDING; REACTIVE OXYGEN METABOLITE;

ALLELE; ANIMAL CELL; ARTICLE; AUTOPHAGOSOME; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHILICITY; HEK293 CELL LINE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; KERATINOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; STEADY STATE; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ANTIOXIDANTS; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; MAP KINASE KINASE KINASES; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTEIN BINDING; PROTEOLYSIS; REACTIVE OXYGEN SPECIES; SEQUESTOSOME-1 PROTEIN;

EID: 85002932956     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2016.6663     Document Type: Article

References (56)

1. Abiko Y, Miura T, Phuc BH, Shinkai Y, and Kumagai Y. Participation of covalent modification of Keap1 in the activation of Nrf2 by tert-butylbenzoquinone, an electrophilic metabolite of butylated hydroxyanisole. Toxicol Appl Pharmacol 255: 32-39, 2011
2. Bae SH, Sung SH, Oh SY, Lim JM, Lee SK, Park YN, Lee HE, Kang D, and Rhee SG. Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab 17: 73-84, 2013
3. Baird L, Lleres D, Swift S, and Dinkova-Kostova AT. Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci U S A 110: 15259-15264, 2013
4. Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, and Johansen T. Monitoring autophagic degradation of p62/ SQSTM1. Methods Enzymol 452: 181-197, 2009
5. Chan K, Lu R, Chang JC, and Kan YW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A 93: 13943-13948, 1996
6. Chowdhry S, Zhang Y, McMahon M, Sutherland C, Cuadrado A, and Hayes JD. Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 32: 3765-3781, 2013
7. Copple IM, Lister A, Obeng AD, Kitteringham NR, Jenkins RE, Layfield R, Foster BJ, Goldring CE, and Park BK. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway. J Biol Chem 285: 16782-16788, 2010
8. Cullinan SB, Gordan JD, Jin J, Harper JW, and Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 24: 8477-8486, 2004
9. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, and Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99: 11908-11913, 2002
10. Eggler AL, Luo Y, van Breemen RB, and Mesecar AD. Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is methoddependent. Chem Res Toxicol 20: 1878-1884, 2007
11. el Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L, Louvard D, Chambon P, Metzger D, and Robine S. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39: 186-193, 2004
12. Franchi L, Munoz-Planillo R, and Nunez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 13: 325-332, 2012
13. Furukawa M and Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol 25: 162-171, 2005
14. Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, and Ralston SH. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Pagets disease. Hum Mol Genet 11: 2735-2739, 2002
15. Huang BW, Ray PD, Iwasaki K, and Tsuji Y. Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4. FASEB J 27: 3763-3774, 2013
16. Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T, Hoshii T, Hirao A, Takagi K, Mizushima T, Motohashi H, Lee MS, Yoshimori T, Tanaka K, Yamamoto M, and Komatsu M. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell 51: 618-631, 2013
17. Inagaki M, Omori E, Kim JY, Komatsu Y, Scott G, Ray MK, Yamada G, Matsumoto K, Mishina Y, and Ninomiya-Tsuji J. TAK1-binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling. J Biol Chem 283: 33080-33086, 2008
18. Inokuchi S, Aoyama T, Miura K, Osterreicher CH, Kodama Y, Miyai K, Akira S, Brenner DA, and Seki E. Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci U S A 107: 844-849, 2010
19. Ishimura R, Tanaka K, and Komatsu M. Dissection of the role of p62/Sqstm1 in activation of Nrf2 during xenophagy. FEBS Lett 588: 822-828, 2014
20. Itoh K, Mimura J, and Yamamoto M. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid Redox Signal 13: 1665-1678, 2010
21. Itoh K, Wakabayashi N, Katoh Y, Ishii T, OConnor T, and Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8: 379-391, 2003
22. Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, McMahon M, Hayes JD, and Johansen T. p62/ SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285: 22576-22591, 2010
23. Jaramillo MC and Zhang DD. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 27: 2179-2191, 2013
24. Kajino-Sakamoto R, Omori E, Nighot PK, Blikslager AT, Matsumoto K, and Ninomiya-Tsuji J. TGF-b-activated kinase signaling maintains intestinal integrity by preventing accumulation of reactive oxygen species in the intestinal epithelium. J Immunol 185: 4729-4737, 2010
25. Kang MI, Kobayashi A, Wakabayashi N, Kim SG, and Yamamoto M. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci U S A 101: 2046-2051, 2004
26. Kawai T and Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650, 2011
27. Kensler TW, Wakabayashi N, and Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116, 2007
28. Kim JY, Omori E, Matsumoto K, Nunez G, and Ninomiya-Tsuji J. TAK1 is a central mediator of NOD2 signaling in epidermal cells. J Biol Chem 283: 137-144, 2008
29. Kirkin V, McEwan DG, Novak I, and Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 34: 259-269, 2009
30. Kishimoto K, Matsumoto K, and Ninomiya-Tsuji J. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem 275: 7359-7364, 2000
31. Kobayashi A, Kang M-I, Watai Y, Tong KI, Shibata T, Uchida K, and Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 26: 221-229, 2006
32. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, and Yamamoto M. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12: 213-U217, 2010
33. Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T, Jiang T, Sun Z, White E, and Zhang DD. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol 30: 3275-3285, 2010
34. Li J, Johnson D, Calkins M, Wright L, Svendsen C, and Johnson J. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol Sci 83: 313-328, 2005
35. Matsumoto G, Shimogori T, Hattori N, and Nukina N. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet 24: 4429-4442, 2015
36. Mihaly SR, Ninomiya-Tsuji J, and Morioka S. TAK1 control of cell death. Cell Death Differ 21: 1667-1676, 2014
37. Moscat J and Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137: 1001-1004, 2009
38. Ninomiya-Tsuji J, Kajino T, Ono K, Ohtomo T, Matsumoto M, Shiina M, Mihara M, Tsuchiya M, and Matsumoto K. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 278: 18485-18490, 2003
39. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, and Matsumoto K. The kinase TAK1 can activate the NIKIjB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252-256, 1999
40. Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, Smart RC, and Ninomiya-Tsuji J. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem 281: 19610-19617, 2006
41. Omori E, Matsumoto K, Zhu S, Smart RC, and Ninomiya-Tsuji J. Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells. Cancer Res 70: 8417-8425, 2010
42. Omori E, Morioka S, Matsumoto K, and Ninomiya-Tsuji J. TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity. J Biol Chem 283: 26161-26168, 2008
43. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, and Mak TW. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467, 1993
44. Rada P, Rojo AI, Chowdhry S, McMahon M, Hayes JD, and Cuadrado A. SCF/b-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol Cell Biol 31: 1121-1133, 2011
45. Rada P, Rojo AI, Offergeld A, Feng GJ, Velasco-Martin JP, Gonzalez-Sancho JM, Valverde AM, Dale T, Regadera J, and Cuadrado A. WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes. Antioxid Redox Signal 22: 555-571, 2015
46. Sanz L, Diaz-Meco MT, Nakano H, and Moscat J. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J 19: 1576-1586, 2000
47. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6: 1087-1095, 2005
48. Taguchi K, Motohashi H, and Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16: 123-140, 2011
49. Takaya K, Suzuki T, Motohashi H, Onodera K, Satomi S, Kensler TW, and Yamamoto M. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radic Biol Med 53: 817-827, 2012
50. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12: 401-410, 2012
51. Wu ZH, Wong ET, Shi Y, Niu J, Chen Z, Miyamoto S, and Tergaonkar V. ATM-and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol Cell 40: 75-86, 2010
52. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, and Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23: 33-42, 1998
53. Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, and Yamamoto M. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28: 2758-2770, 2008
54. Yang Y, Xia F, Hermance N, Mabb A, Simonson S, Morrissey S, Gandhi P, Munson M, Miyamoto S, and Kelliher MA. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-jB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol Cell Biol 31: 2774-2786, 2011
55. Zhang DD and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23: 8137-8151, 2003
56. Zhong Z, Umemura A, Sanchez-Lopez E, Liang S, Shalapour S, Wong J, He F, Boassa D, Perkins G, Ali SR, McGeough MD, Ellisman MH, Seki E, Gustafsson AB, Hoffman HM, Diaz-Meco MT, Moscat J, and Karin M. NF-jB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell 164: 896-910, 2016